Prox Ventures

Prox Ventures is a Shanghai-based early-stage investor targeting digital health applications and niche healthcare service platforms at seed and Series A. The firm’s healthcare exposure spans digital health and health IT software, suggesting an appetite for nimble teams building point solutions or vertical platforms within the broader Chinese healthcare technology landscape. The Shanghai base places the firm in a dense ecosystem of healthcare startups and prospective hospital partners. Limited public information about named partners, specific portfolio companies, and fund vintages is available in English-language sources, so founders should expect to validate scope directly.

Check sizes range from 250,000 to 1 million dollars at seed and Series A, sized for early-stage capital that supports product development and initial commercial validation rather than late-stage scaling. Geography centers on China with Shanghai as the operating base, and the firm is positioned to support founders building for Chinese hospital, clinic, or consumer healthcare customers. Companies focused outside the Chinese healthcare ecosystem will not align with the thesis.

The approach suits founders looking for nimble, founder-friendly early capital with local fluency in Chinese digital health dynamics. Those needing large initial checks, deep biotech regulatory expertise, or international syndicate leadership should plan to syndicate accordingly with larger funds. The right candidates are early-stage software or services teams with credible early traction in their specific healthcare niche. Initial conversations should focus on the company’s wedge into the Chinese healthcare market, evidence of early commercial validation, and the specific operational support Prox Ventures offers beyond capital, particularly around customer introductions and follow-on syndicate construction for the Series A and Series B.